Cargando…
Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome
The blood-brain barrier (BBB) presents a formidable challenge in the development of effective therapeutics in neuro-oncology. This has fueled several decades of efforts to develop strategies for disrupting the BBB, but progress has not been satisfactory. As such, numerous drug- and device-based meth...
Autores principales: | Karmur, Brij S., Philteos, Justine, Abbasian, Aram, Zacharia, Brad E., Lipsman, Nir, Levin, Victor, Grossman, Stuart, Mansouri, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531249/ https://www.ncbi.nlm.nih.gov/pubmed/33072591 http://dx.doi.org/10.3389/fonc.2020.563840 |
Ejemplares similares
-
Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic Diseases
por: Meng, Ying, et al.
Publicado: (2018) -
Untapped Neuroimaging Tools for Neuro-Oncology: Connectomics and Spatial Transcriptomics
por: Germann, Jurgen, et al.
Publicado: (2022) -
CLRM-11. BENCH TO BEDSIDE NEURO-ONCOLOGY: ADVOCATING FOR A CLINICALLY RELEVANT STRATEGY AS UNDERSCORED BY THE PANDEMIC
por: Brown, Timothy, et al.
Publicado: (2021) -
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier
por: Lampson, Lois A
Publicado: (2011) -
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey
por: Rogers, James L, et al.
Publicado: (2020)